Heart disease is the leading cause of death for people of most racial and ethnic groups in the United States. Cardiovascular disease-related deaths—which occur every 36 seconds—cost our country about $219 billion each year, according to the Centers for Disease Control and Prevention (CDC). People with poor cardiovascular health are also at increased risk of severe illness from COVID-19, so the time to act is now. There’s no time like the present to look at major risk factors—from obesity and
Read More
Giving ‘Voice’ to Healthcare: The $3.5 Billion Opportunity
Whether it's asking Siri for directions to the nearest coffee shop or commanding Alexa to turn on the lights, using voice assistants has become part of daily routines. More than one-third of the U.S. population relies on these tools to make their lives easier, and they’re being embraced by more than just millennials; use among seniors, children, and teens is also on the rise. But the home and smartphone aren’t the only domains for voice assistants. Businesses of all types – from
Read More
NarrativeDx Raises $3M for Patient Experience Intelligence Platform
NarrativeDx, an Austin, TX-based artificial intelligence (AI) company that provides actionable insights from patient and provider feedback, today announced it has raised $3 million in strategic funding led by Christiana Care Health System, Summation Health Ventures and The Texas Medical Center. Also joining the round are HealthX Ventures and Cultivation Capital, who participated in previous rounds of funding. NarrativeDx will use the funds to accelerate sales and marketing, product innovation,
Read More
Emedgene Lands $6M to Expand AI-Driven Genomics Interpretation Platform
Emedgene, a Palo Alto, CA-based artificial intelligence (AI) driven genomics interpretation platform, today announced it has raised $6 million in funding led by health-focused OliveTree Ventures. The company plans to utilize the latest round of funding to expand sales operations in the US. Emedgene's Genomics Intelligence Platform OverviewThis rise in genomics-based medicine is putting tremendous pressure on geneticists globally - who must analyze and interpret each test. It is a costly,
Read More
doc.ai Raises $2.3M in Pre-ICO for Blockchain-Enabled NLP for Quantified Biology
doc.ai Incorporated (“doc.ai”), a San Francisco, CA-based digital health startup building an advanced natural language processing technology platform for quantified biology has raised $2.3 million in pre-ICO (initial coin offering) or initial sale of Simple Agreements for Future Tokens ("SAFTs"). A total of ten purchasers acquired SAFTs led by Pantera Capital.The early pre-sale of doc.ai's SAFTs, which are convertible into digital tokens named Neurons ("NRNs"), was limited to existing investors
Read More
doc.ai Launches First Blockchain-Enabled NLP for Quantified Biology
doc.ai Incorporated ("doc.ai"), a San Francisco, CA-based digital health startup has announced the launch of its blockchain-enabled natural language processing (NLP) platform for quantified biology. Founded by the entrepreneurial Walter De Brouwer in 2016, doc.ai utilizes the blockchain to timestamp its datasets and decentralize artificial intelligence to generate insights from combined medical data.doc.ai is building a new platform for established medical companies to enable patients to have
Read More
Video:Understanding NLP Technology with 3M
Imminent delay of ICD-10 has not stopped the healthcare providers who have the foresight to charge ahead in their preparation for ICD-10. One of the biggest components that would assist healthcare organizations in that preparation for ICD-10 is purchasing a Computer Assisted Coding software product. One of the key components of a computer assisted coding product is it's Natural Language Processing (NLP) technology that provides the ability to highlight code-able terms in the patient record by
Read More
